Skip to Main Content
our new site.
NLM Technical Bulletin
Full Text View
No Study Results Posted
Phase 2 Study of S-1 as 2nd Line Therapy in Metastatic Pancreatic Cancer
This study has been completed.
Study NCT00652054 Information provided by Taiho Pharma USA, Inc.
First Received on March 31, 2008. Last Updated on March 17, 2011
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Neoplasms, Second Primary
More general conditions related to this trial
Digestive System Diseases
Digestive System Neoplasms
Endocrine Gland Neoplasms
Endocrine System Diseases
Neoplasms by Site
Interventions listed in this trial
Sponsors listed in this trial
Taiho Pharma USA, Inc.
Back to top of Main Content
Contact Help Desk
Lister Hill National Center for Biomedical Communications
U.S. National Library of Medicine
U.S. National Institutes of Health
U.S. Department of Health & Human Services
Freedom of Information Act
Links to all studies - primarily for crawlers